← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

▼ SELL 10b5-1 Plan

$ Value

$1.2M

Shares

41,076

Price

$30

Filed

Mar 27

Insider

Name

Anderson Karen M.

Title

Chief People Officer

CIK

0001762176

Roles

Officer

Transaction Details

Transaction Date

2026-03-26

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

62,085

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.99 to $30.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | 1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.

Filing Info

Accession No.

0001470831-26-000331

Form Type

4

Issuer CIK

0001847903

Anderson Karen M.'s History

Date Ticker Type Value
2026-03-26 CNTA M $329K
2026-03-26 CNTA $1.2M
2026-03-26 CNTA M $0
2026-03-17 CNTA M $40K
2026-03-17 CNTA $282K
2026-03-17 CNTA M $0
2026-03-16 CNTA M $260K
2026-03-16 CNTA $1.8M
2026-03-16 CNTA M $0
2026-03-13 CNTA M $439K

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Kanes Stephen
Chief Medical Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$5.3M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02